ghk-cu typical daily dose subcutaneous injection Dosage: Clinical Guidance for Safe Administration – PlexusDx MOTS-C Dosing Guide: Recommended Dose

Growth Factor Gene Expression Growth factor gene expression increases substantially across multiple pathways: VEGF (Vascular Endothelial Growth Factor) Shows dose-dependent increases in mesenchymal stem cells, promoting angiogenesis and blood vessel formation bFGF (Basic Fibroblast Growth Factor) Increases 230% when combined with LED irradiation at 625-635 nm wavelengths BDNF (Brain-Derived Neurotrophic Factor) Receives stimulation for nerve outgrowth and neurological support ANGPT1 (Angiopoietin 1) Increases 487% for vascular stabilization BMP-2 (Bone Morphogenetic Protein 2) Receives upregulation for bone tissue regeneration Inflammatory Pathway Suppression Inflammatory pathway suppression occurs through multiple mechanisms

Improvements in skin texture typically appear within 46 weeks, with optimal results after 812 weeks of consistent use

This dose should be maintained for at least four weeks to assess tolerance and initial therapeutic response before considering further dose escalation

However, strong acids, high levels of vitamin C, and chelators may affect stability